Overview

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

Status:
Not yet recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
This study is a phase 2 study of SHR-1905 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of SHR-1905 in subjects with severe uncontrolled asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.